|
GB0112235D0
|
|
The treatment of anorexia nervosa
|
|
GB0107957D0
|
|
Metal carboxylates
|
|
GB0026593D0
|
|
Derivatised carbohydrates and their use in solid delivery systems
|
|
AU1152701A
|
|
Platelet stabilisation
|
|
GB0020616D0
|
|
Particulates
|
|
US6331310B1
|
|
Solid dose delivery vehicle and methods of making same
|
|
GB0018772D0
|
|
Stabilised prokaryotic cells
|
|
GB0012370D0
|
|
Peptoids
|
|
GB0012372D0
|
|
Platelet stabilisation
|
|
GB0011807D0
|
|
Formulation for inhalation
|
|
GB0004827D0
|
|
Compositions
|
|
GB9926838D0
|
|
Methods for incorporating carbohydrates into platelets
|
|
AU5751799A
|
|
Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
|
|
GB9917444D0
|
|
Stabilised prokaryotic cells
|
|
GB9916316D0
|
|
Dry powder compositions
|
|
GB9904049D0
|
|
Rapidly-soluble compositions
|
|
US6352722B1
|
|
Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
|
|
GB9818133D0
|
|
Vaccine
|
|
AU8229998A
|
|
Modified glycosides, compositions comprised thereof and methods of use thereof
|
|
AU7186498A
|
|
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
